Coombe, Bender & CO LLC Pfizer Inc Transaction History

Coombe, Bender & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $302,689 - $393,160	11,584 New	11,584 $333,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $403,747 - $525,620	10,250 New	10,250 $418,000
Q3 2022 Nov 22, 2022	BUY	$43.76 - $53.42 $1,225 - $1,495	28 Added 0.27%	10,237 $448,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $475,024 - $563,230	10,209 New	10,209 $535,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Coombe, Bender & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Coombe, Bender & CO LLC with notifications on news.